Development of a Machine Learning Model for Prostate Cancer Treatment Planning
The purpose of this study is to contribute radiation treatment plans for prostate cancer from 2015-2016 to a third-party group. That group will be developing artificial intelligence and machine learning to see if they can increase quality and efficiency of radiation therapy plans.
Eligible patients are between ages 21-90 who had confirmed prostate cancer that was treated with radiation therapy between 1/1/2015 and 12/31/2016. Must not have had other prior radiation or surgery of the prostate.
21 - 90
Healthy Volunteers Needed
Duration of Participation
Participation will entail an extra 15 minutes or so at only one regularly-scheduled follow up visit.